300 related articles for article (PubMed ID: 21246350)
1. Adverse drug events in an intensive care unit of a university hospital.
Reis AM; Cassiani SH
Eur J Clin Pharmacol; 2011 Jun; 67(6):625-32. PubMed ID: 21246350
[TBL] [Abstract][Full Text] [Related]
2. Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.
Carayon P; Wetterneck TB; Cartmill R; Blosky MA; Brown R; Kim R; Kukreja S; Johnson M; Paris B; Wood KE; Walker J
BMJ Qual Saf; 2014 Jan; 23(1):56-65. PubMed ID: 24050986
[TBL] [Abstract][Full Text] [Related]
3. Influence of adverse drug events on morbidity and mortality in intensive care units: the JADE study.
Ohta Y; Sakuma M; Koike K; Bates DW; Morimoto T
Int J Qual Health Care; 2014 Dec; 26(6):573-8. PubMed ID: 25192926
[TBL] [Abstract][Full Text] [Related]
4. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.
Aljadhey H; Mahmoud MA; Ahmed Y; Sultana R; Zouein S; Alshanawani S; Mayet A; Alshaikh MK; Kalagi N; Al Tawil E; El Kinge AR; Arwadi A; Alyahya M; Murray MD; Bates D
BMJ Open; 2016 Jul; 6(7):e010831. PubMed ID: 27406640
[TBL] [Abstract][Full Text] [Related]
5. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
[TBL] [Abstract][Full Text] [Related]
6. Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit.
Kane-Gill S; Rea RS; Verrico MM; Weber RJ
Am J Health Syst Pharm; 2006 Oct; 63(19):1876-81. PubMed ID: 16990635
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.
Sevilla-Sanchez D; Molist-Brunet N; Amblàs-Novellas J; Roura-Poch P; Espaulella-Panicot J; Codina-Jané C
Eur J Clin Pharmacol; 2017 Jan; 73(1):79-89. PubMed ID: 27704168
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug events identified by triggers at a teaching hospital in Brazil.
Giordani F; Rozenfeld S; Martins M
BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
[TBL] [Abstract][Full Text] [Related]
9. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study.
Klopotowska JE; Leopold JH; Bakker T; Yasrebi-de Kom I; Engelaer FM; de Jonge E; Haspels-Hogervorst EK; van den Bergh WM; Renes MH; Jong BT; Kieft H; Wieringa A; Hendriks S; Lau C; van Bree SHW; Lammers HJW; Wierenga PC; Bosman RJ; de Jong VM; Slijkhuis M; Franssen EJF; Vermeijden WJ; Masselink J; Purmer IM; Bosma LE; Hoeksema M; Wesselink E; de Lange DW; de Keizer NF; Dongelmans DA; Abu-Hanna A
Br J Clin Pharmacol; 2024 Jan; 90(1):164-175. PubMed ID: 37567767
[TBL] [Abstract][Full Text] [Related]
11. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries.
Anthes AM; Harinstein LM; Smithburger PL; Seybert AL; Kane-Gill SL
Pharmacoepidemiol Drug Saf; 2013 May; 22(5):510-6. PubMed ID: 23440931
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study.
Eshetie TC; Hailemeskel B; Mekonnen N; Paulos G; Mekonnen AB; Girma T
BMC Pediatr; 2015 Jul; 15():83. PubMed ID: 26173560
[TBL] [Abstract][Full Text] [Related]
14. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
Kunac DL; Kennedy J; Austin N; Reith D
Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
[TBL] [Abstract][Full Text] [Related]
15. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
[TBL] [Abstract][Full Text] [Related]
16. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic.
Maříková M; Očovská Z; Nerad V; Kuběna AA; Blaha V; Vlček J
Int J Clin Pharm; 2021 Oct; 43(5):1218-1226. PubMed ID: 33763812
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug events in critically ill patients with cancer: incidence, characteristics, and outcomes.
Nazer LH; Hawari F; Al-Najjar T
J Pharm Pract; 2014 Apr; 27(2):208-13. PubMed ID: 24319079
[TBL] [Abstract][Full Text] [Related]
18. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
19. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
[TBL] [Abstract][Full Text] [Related]
20. Life-Threatening and Fatal Adverse Drug Events in a Danish University Hospital.
Tchijevitch OA; Nielsen LP; Lisby M
J Patient Saf; 2021 Sep; 17(6):e562-e567. PubMed ID: 28753137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
